Retraction

miR-539 enhances chemosensitivity to cisplatin in non-small cell lung cancer by targeting DCLK1

Paper Information

Record ID:

43215

Author(s):

Huixing Deng
Qianqian Geng
Ting Ji
Aimin Yang

Journal:

Biomedicine & Pharmacotherapy ( Elsevier )

Publication Date:

July 17, 2018

Retraction Date:

March 14, 2023 (2.7 years years ago)

Subjects:

Broad Categories:
Biology Genetics

Specific Fields:
Biology - Cancer Biology - Cellular Genetics

Institution:

Department of Nuclear Medicine, The First Affiliated Hospital of Xi’an Jiaotong University, Xi’an, 710061, China

Country:

🇨🇳 China

Article Type:

Research Article

Publisher:

Elsevier

Open Access:

Yes

DOI:

10.1016/j.biopha.2018.07.024

PubMed ID:

30119173

Retraction PubMed ID:

37087344

Retraction Details

Retraction Reasons:

Nature of Retraction:

Retraction

Retraction Notice:

10.1016/j.biopha.2023.114720

Additional Notes:

date of retraction unknown, html page overwrite, date estimated from notifications; see also: https://pubpeer.com/publications/96CACC6C7EAE327217D2319DC364C5; see also: https://www.sciencedirect.com/science/article/pii/S075333222201201X?via%3Dihub; separate retraction notice published later date 4/20/2023;

Citations (44)

44

Total Citations

6

Post-Retraction
(13.6%)

38

Pre-Retraction

0

Same Day

Post-Retraction Citation Analysis

0 Within 30 days

3 Within 1 year

1 After 2+ years

781 Days since retraction (latest)

Association Between miR-539 and miR-6824 and Their Target Gene, MAP2K1, Expression Level in Oral Cancer

Sara Jalali Farahani, Farzaneh Jahangiri, Faranak Jamshidian et al. (4 authors)

Indian Journal of Surgical Oncology

Published: May 2025

781 days after retraction

MicroRNAs in lung cancer: their role in tumor progression, biomarkers, diagnostic, prognostic, and therapeutic relevance

Madhura Chatterjee, Sayoni Nag, Saurabh Gupta et al. (8 authors)

Discover Oncology Open Access

Published: Mar 2025
1 citation

728 days after retraction

Exosome therapeutics for non-small cell lung cancer tumorigenesis

Niloufar Orooji, Manouchehr Fadaee, Tohid Kazemi et al. (4 authors)

Cancer Cell International Open Access

Published: Oct 2024
14 citations

596 days after retraction

Emerging role of competing endogenous RNA in lung cancer drug resistance

Shijie Wu, Ting Luo, Xiaoyong Lei et al. (4 authors)

Journal of Chemotherapy

Published: Dec 2023

281 days after retraction

Design and synthesis of doublecortin-like kinase 1 inhibitors and their bioactivity evaluation

Pengming Pan, Dengbo Ji, Zhongjun Li et al. (4 authors)

Journal of Enzyme Inhibition and Medicinal Chemistry Open Access

Published: Dec 2023
1 citation

268 days after retraction

Regulation and therapeutic potentials of microRNAs to non-small cell lung cancer

Mai Thi Le, Nguyen Thu Huyen, Xuan‐Hung Nguyen et al. (8 authors)

Heliyon Open Access

Published: Nov 2023
8 citations

232 days after retraction

MicroRNAs and Drug Resistance in Non-Small Cell Lung Cancer: Where Are We Now and Where Are We Going

Roberto Cuttano, Miriam Kuku Afanga, Fabrizio Bianchi

Cancers Open Access

Published: Nov 2022
4 citations

112 days before retraction

Exploration of a Novel Circadian miRNA Pair Signature for Predicting Prognosis of Lung Adenocarcinoma

Zhengrong Yin, Jingjing Deng, Mei Zhou et al. (9 authors)

Cancers Open Access

Published: Oct 2022
2 citations

147 days before retraction

Potential therapeutic applications of microRNAs in cancer diagnosis and treatment: Sharpening a double-edged sword?

Mahasin Abdel Rhman, Owira PMO

European Journal of Pharmacology

Published: Aug 2022
10 citations

211 days before retraction

A study of miRNAs as cornerstone in lung cancer pathogenesis and therapeutic resistance: A focus on signaling pathways interplay

Ahmed S. Doghish, Ahmed Ismail, Mahmoud A. Elrebehy et al. (12 authors)

Pathology - Research and Practice

Published: Jul 2022
71 citations

227 days before retraction

MicroRNAs as Predictors of Lung-Cancer Resistance and Sensitivity to Cisplatin

Maria Konoshenko, Yuriy Lansukhay, Sergey E. Krasilnikov et al. (4 authors)

International Journal of Molecular Sciences Open Access

Published: Jul 2022
22 citations

249 days before retraction

MALAT1 enhances gemcitabine resistance in non-small cell lung cancer cells by directly affecting miR-27a-5p/PBOV1 axis

Wenyu Chen, Xiaoli Tan, Qi Yang et al. (5 authors)

Cellular Signalling

Published: Mar 2022
20 citations

348 days before retraction

DCLK1 and its interaction partners: An effective therapeutic target for colorectal cancer (Review)

Muthu Vijai, Mursaleen Baba, Satish Ramalingam et al. (4 authors)

Oncology Letters Open Access

Published: Oct 2021
16 citations

504 days before retraction

MiR-133a-3p overexpression-induced elevation of cisplatin-mediated chemosensitivity to non-small cell lung cancer by targeting replication factor C3

Guanqun Dai, Shencun Fang, Hui Kong et al. (6 authors)

Process Biochemistry

Published: Oct 2021

505 days before retraction

Circular RNA circ-RNF121 contributes to cisplatin (DDP) resistance of non-small-cell lung cancer cells by regulating the miR-646/SOX4 axis

Yongrui Liu, Ruiren Zhai, Siqin Hu et al. (4 authors)

Anti-Cancer Drugs

Published: Aug 2021
13 citations

580 days before retraction

Long intergenic non-protein coding RNA 460: Review of its role in carcinogenesis

Soudeh Ghafouri‐Fard, Tayyebeh Khoshbakht, Mohammad Taheri et al. (4 authors)

Pathology - Research and Practice

Published: Jul 2021
5 citations

602 days before retraction

Serum miR-27a is a biomarker for the prognosis of non-small cell lung cancer patients receiving chemotherapy

Erfu Xie, Mingxin Lin, Ziwei Sun et al. (9 authors)

Translational Cancer Research Open Access

Published: Jun 2021
7 citations

637 days before retraction

The effect of miR-539 regulating TRIAP1 on the apoptosis, proliferation, migration and invasion of osteosarcoma cells

Huowen Liu, Min Yang, Yufeng Zhang et al. (8 authors)

Cancer Cell International Open Access

Published: Apr 2021
14 citations

693 days before retraction

LncRNA SNHG1 contributes to the cisplatin resistance and progression of NSCLC via miR-330-5p/DCLK1 axis

Ge Peng, Lei Cao, Ming Zheng et al. (6 authors)

Experimental and Molecular Pathology

Published: Mar 2021
35 citations

725 days before retraction

Identification of potential novel drug resistance mechanisms by genomic and transcriptomic profiling of colon cancer cells with p53 deletion

Onat Kadioglu, Mohamed E.M. Saeed, Nuha Mahmoud et al. (7 authors)

Archives of Toxicology Open Access

Published: Jan 2021
10 citations

773 days before retraction

Knockdown of cir_RNA PVT1 Elevates Gastric Cancer Cisplatin Sensitivity via Sponging miR-152-3p

Xiaojie Wang, Ying Zhang, Wei Li et al. (4 authors)

Journal of Surgical Research

Published: Jan 2021
36 citations

790 days before retraction

MicroRNAs and Lung Cancer: A Review Focused on Targeted Genes

Yaohui Wang, Zhiruo Zhu, De Tong et al. (6 authors)

Exploratory Research and Hypothesis in Medicine Open Access

Published: Jan 2021
5 citations

792 days before retraction

Progress of exosomes in the diagnosis and treatment of lung cancer

Kanghong Xu, Chengpeng Zhang, Tiantian Du et al. (10 authors)

Biomedicine & Pharmacotherapy Open Access

Published: Dec 2020
146 citations

810 days before retraction

Extracellular vesicles‐encapsulated let‐7i shed from bone mesenchymal stem cells suppress lung cancer via KDM3A/DCLK1/FXYD3 axis

Jiefeng Liu, Yuhua Feng, Xinyu Zeng et al. (6 authors)

Journal of Cellular and Molecular Medicine Open Access

Published: Dec 2020
41 citations

812 days before retraction

Lung cancer cells and their sensitivity/resistance to cisplatin chemotherapy: Role of microRNAs and upstream mediators

Milad Ashrafizadeh, Ali Zarrabi, Kiavash Hushmandi et al. (11 authors)

Cellular Signalling

Published: Dec 2020
126 citations

830 days before retraction

Construction and investigation of a combined hypoxia and stemness index lncRNA-associated ceRNA regulatory network in lung adenocarcinoma

Lili Guo, Hongxia Li, Weiying Li et al. (4 authors)

BMC Medical Genomics Open Access

Published: Nov 2020
17 citations

860 days before retraction

<scp>MiR</scp>‐133a acts as a tumor suppressor in lung cancer progression by regulating the <scp>LASP1</scp> and <scp>TGF</scp>‐β/Smad3 signaling pathway

Yuyao Shen, Yan Yang, Yahua Li

Thoracic Cancer Open Access

Published: Oct 2020
22 citations

876 days before retraction

The anti-tumor effect of miR-539-3p on colon cancer via regulating cell viability, motility, and nude mouse tumorigenicity with CDK14 inhibition

Zhuo Wang, Tao Hu, Chengwu Jin et al. (6 authors)

Journal of Gastrointestinal Oncology Open Access

Published: Oct 2020
7 citations

894 days before retraction

Knockdown of Long Non-Coding RNA HOTAIR Suppresses Cisplatin Resistance, Cell Proliferation, Migration and Invasion of DDP-Resistant NSCLC Cells by Targeting miR-149-5p/Doublecortin-Like Kinase 1 Axis

Yiyi Zhan, Kahaerjiang Abuduwaili, Xiuli Wang et al. (6 authors)

Cancer Management and Research Open Access

Published: Aug 2020
19 citations

955 days before retraction

DCLK1 inhibition attenuates tumorigenesis and improves chemosensitivity in esophageal squamous cell carcinoma by inhibiting β-catenin/c-Myc signaling

Lianqun Zhang, Shengli Zhou, Er-Tao Guo et al. (6 authors)

Pflügers Archiv - European Journal of Physiology

Published: Jun 2020
12 citations

1005 days before retraction

MicroRNA‑654‑3p enhances cisplatin sensitivity by targeting QPRT and inhibiting the PI3K/AKT signaling pathway in ovarian cancer cells

Yichao Niu, Jing Tong, Xiaofei Shi et al. (4 authors)

Experimental and Therapeutic Medicine Open Access

Published: Jun 2020
21 citations

1006 days before retraction

DCLK1 Regulates Tumor Stemness and Cisplatin Resistance in Non-small Cell Lung Cancer via ABCD-Member-4

Janani Panneerselvam, Priyanga Mohandoss, Ravi B. Patel et al. (15 authors)

Molecular Therapy — Oncolytics Open Access

Published: May 2020
39 citations

1021 days before retraction

miR‑539 suppresses the proliferation, migration, invasion and epithelial mesenchymal transition of pancreatic cancer cells through targeting SP1

Xue Liang, Yan Shen, Zheng-long Zhai et al. (4 authors)

International Journal of Molecular Medicine Open Access

Published: Apr 2020
10 citations

1077 days before retraction

Role of non-coding RNAs and RNA modifiers in cancer therapy resistance

Xinyi Zhang, Kai Xie, Honghua Zhou et al. (11 authors)

Molecular Cancer Open Access

Published: Mar 2020
210 citations

1107 days before retraction

MiR-539 inhibits the malignant behavior of breast cancer cells by targeting SP1

Fenglin Cai, Luhong Chen, Yuting Sun et al. (6 authors)

Biochemistry and Cell Biology

Published: Nov 2019
26 citations

1211 days before retraction

Application of RNA-sequencing to identify transcriptome modification by DCLK1 in colorectal cancer cells

Lianna Li, Hao Mei, Abednego Nii Adom Commey

Cancer Gene Therapy Open Access

Published: Oct 2019
1 citation

1240 days before retraction

miR‐605‐5p promotes invasion and proliferation by targeting TNFAIP3 in non–small‐cell lung cancer

Youxia Liao, Lirong Cao, Fang Wang et al. (4 authors)

Journal of Cellular Biochemistry Open Access

Published: Aug 2019
25 citations

1296 days before retraction

miR-324-5p upregulation potentiates resistance to cisplatin by targeting FBXO11 signalling in non-small cell lung cancer cells

Zhichang Ba, Yufei Zhou, Zhaoyang Yang et al. (5 authors)

The Journal of Biochemistry

Published: Aug 2019
20 citations

1300 days before retraction

Cisplatin decreases cyclin D2 expression via upregulating miR‑93 to inhibit lung adenocarcinoma cell growth

Ning Xie, Yuanrong Liu, Yanmei Li et al. (9 authors)

Molecular Medicine Reports Open Access

Published: Aug 2019
5 citations

1316 days before retraction

Lidocaine inhibits proliferation and metastasis of lung cancer cell via regulation of miR-539/EGFR axis

Hai Sun, Yan Sun

Artificial Cells Nanomedicine and Biotechnology Open Access

Published: Jul 2019
79 citations

1341 days before retraction

MicroRNA‑214 upregulates HIF‑1α and VEGF by targeting ING4 in lung cancer cells

Yue Li, Long Zhao, Yafei Qi et al. (4 authors)

Molecular Medicine Reports Open Access

Published: Apr 2019
12 citations

1428 days before retraction

Over-expression of miR-206 decreases the Euthyrox-resistance by targeting MAP4K3 in papillary thyroid carcinoma

Fangzhou Liu, Rong Yin, Xinyuan Chen et al. (12 authors)

Biomedicine & Pharmacotherapy Open Access

Published: Mar 2019
37 citations

1454 days before retraction

Doublecotin-like kinase 1 increases chemoresistance of colorectal cancer cells through the anti-apoptosis pathway

Lianna Li, Kierra Jones, Hao Mei

bioRxiv (Cold Spring Harbor Laboratory) Open Access

Published: Jan 2019
9 citations

1524 days before retraction

Doublecotin-Like Kinase 1 Increases Chemoresistance of Colorectal Cancer Cells through the Anti-Apoptosis Pathway.

Lianna Li, Kierra Jones, Hao Mei

PubMed

Published: Jan 2019
9 citations

1533 days before retraction

Related Records

This article has multiple records in the database due to different notices:

Record #43216

Oct 18, 2022

Expression of concern

Quick Stats

Total Citations: 44

Years Since Retraction: 2.7 years

Open Access: Yes

Last Checked: Jul 24, 2025

Actions

More from this journal Similar subjects View Original Paper View Retraction Notice